‘Hold the Phone,’ Says Morgan Stanley on Hims & Hers Health Stock (HIMS)
Hims & Hers Health (HIMS) is trying its best to stay relevant in the multi-billion dollar obesity treatment market. Despite a ...
11 Top Press Releases from March
With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...
Fierce Healthcare18h
DTC obesity med market heats up: Eli Lilly taps knownwell, Hims & Hers adds new weight loss meds to platform
Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...
Glenwood Springs Post Independent12hOpinion
Feinsinger column: Ozempic and other GLP-1 weight-loss drugs
Dr. Michael Greger is famous for several books including “How Not to Die,” and for his website nutritionfacts.org. He ...
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Delish on MSN19h
Costco Quietly Killed Ozempic Discounts—Here's What We Know
Costco made waves when it introduced a weight loss management program through its healthcare marketplace partner, Sesame. With a Costco membership, customers could acce ...
Le Lézard12m
March Recap: 15 Top Health Press Releases
With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the month's most ...
Santa Maria Times22hOpinion
In defense of the nation’s colleges and universities | Guest Commentary
Our institutions of higher learning produce much that is good and noble in our society, as they have for many decades.